NGO health care clinic Kruispost, Amsterdam, The Netherlands.
Department of Infectious Diseases, Public Health Service Amsterdam (GGD), Amsterdam, The Netherlands.
PLoS One. 2021 Oct 29;16(10):e0258932. doi: 10.1371/journal.pone.0258932. eCollection 2021.
Migrants are not routinely screened for hepatitis B virus (HBV), hepatitis C virus (HCV) and human immunodeficiency virus (HIV) in the Netherlands. We estimated the prevalence and determined factors associated with HBV, HCV and/or HIV infections among undocumented migrants and uninsured legal residents.
In this cross-sectional study, undocumented migrants and uninsured legal residents were recruited at a non governmental organization (NGO), healthcare facility in the Netherlands and were invited to be tested for hepatitis B surface antigen (HBsAg), anti-hepatitis B core antibodies (anti-HBcAb), HCV-RNA, and anti-HIV antibodies or HIV antigen at a local laboratory.
Of the 1376 patients invited, 784 (57%) participated. Participants originated from Africa (35%), Asia (30%) and North/South America (30%). 451/784 (58%) participants went to the laboratory for testing. Of participants 30% were HBV exposed (anti-HBcAb-positive), with 27% (n = 119/438, 95% CI 23.1% to 31.6%) having resolved HBV infection (HBsAg-negative) and 2.5% (n = 11/438, 95%CI 1.3% to 4.5%, 64% new infection) having chronic HBV infection (HBsAg-positive). Compared to HBV non-exposed, HBV exposed individuals were older (p = 0.034) and more often originated from Africa (p<0.001). Prevalence of chronic HCV infection (HCV-RNA-positive) was 0.7% (n = 3/435, 95%CI 0.1% to 2.0%, all new infections) and HIV infection 1.1% (n = 5/439, 95%CI 0.04% to 2.6%, 40% new infection).
Prevalence of chronic HBV, chronic HCV and HIV infections in our study population is higher compared to the Dutch population, thus emphasizing the importance of case finding for these infections through primary care and public health in this specific group of migrants. Screening uptake could be improved by on-site testing.
在荷兰,移民通常不会接受乙型肝炎病毒(HBV)、丙型肝炎病毒(HCV)和人类免疫缺陷病毒(HIV)的常规筛查。我们评估了无证移民和无保险合法居民中 HBV、HCV 和/或 HIV 感染的流行率,并确定了与这些感染相关的因素。
在这项横断面研究中,我们在荷兰的一个非政府组织(NGO)和医疗保健机构招募了无证移民和无保险合法居民,并邀请他们在当地实验室接受乙型肝炎表面抗原(HBsAg)、抗乙型肝炎核心抗体(抗-HBcAb)、HCV-RNA 和抗 HIV 抗体或 HIV 抗原检测。
在邀请的 1376 名患者中,有 784 名(57%)参加。参与者来自非洲(35%)、亚洲(30%)和北美/南美(30%)。有 451/784(58%)名参与者前往实验室进行检测。30%的参与者有 HBV 暴露史(抗-HBcAb 阳性),其中 27%(n=119/438,95%CI 23.1%至 31.6%)已清除 HBV 感染(HBsAg 阴性),2.5%(n=11/438,95%CI 1.3%至 4.5%,64%为新感染)有慢性 HBV 感染(HBsAg 阳性)。与 HBV 未暴露者相比,HBV 暴露者年龄更大(p=0.034),且更常来自非洲(p<0.001)。慢性 HCV 感染(HCV-RNA 阳性)的流行率为 0.7%(n=3/435,95%CI 0.1%至 2.0%,均为新感染),HIV 感染率为 1.1%(n=5/439,95%CI 0.04%至 2.6%,40%为新感染)。
与荷兰人群相比,我们研究人群中慢性 HBV、慢性 HCV 和 HIV 感染的流行率更高,因此强调了在这一特定移民群体中通过初级保健和公共卫生发现这些感染的重要性。通过现场检测可以提高筛查参与度。